|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 27.00 USD | +0.04% |
|
-.--% | +67.18% |
| 06-14 | KalVista Pharmaceuticals, Inc.(NasdaqGM:KALV) dropped from Russell 2000 Growth Index | CI |
| 06-14 | KalVista Pharmaceuticals, Inc.(NasdaqGM:KALV) dropped from Russell Small Cap Comp Growth Index | CI |
| Market Cap | 1.44B 1.26B 1.16B 1.08B 2.04B 137B 2.07B 13.88B 5.4B 67.31B 5.4B 5.28B 233B | P/E 2024 |
-2.46x | P/E 2025 | -5.3x |
|---|---|---|---|---|---|
| Enterprise Value | 1.42B 1.24B 1.15B 1.06B 2.02B 136B 2.05B 13.73B 5.34B 66.56B 5.34B 5.22B 231B | EV / Sales 2024 |
-
| EV / Sales 2025 | 10.9x |
| Free-Float |
-
| Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: KalVista Pharma
| 1 day | +0.04% | ||
| 1 month | +0.19% | ||
| 3 months | +33.73% | ||
| 6 months | +71.43% | ||
| Current year | +67.18% |
| 1 month | 26.97 |  | 27 |
| Current year | 14.22 | | 27 |
| 1 year | 10.41 | | 27 |
| 3 years | 7.21 | | 27 |
| 5 years | 4.12 | | 27 |
| 10 years | 0 | | 45 |
| Manager | Title | Age | Since |
|---|---|---|---|
Ed Feener
CTO | Chief Tech/Sci/R&D Officer | 66 | 2016-10-31 |
Ben Palleiko
CEO | Chief Executive Officer | 61 | 2024-03-05 |
John Hess
PSD | President | - | 2026-06-10 |
| Director | Title | Age | Since |
|---|---|---|---|
John Hess
CHM | Chairman | - | 2026-06-10 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 06-10 | Issuer sale | Director | -17,000 | 0.0336% | ||
| 06-10 | Issuer sale | Chief Technology Officer | -478,560 | 0.9468% | ||
| 06-10 | Issuer sale | Director | -109,000 | 0.2156% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | 73.62M 64.47M 59.38M 55.12M 105M 7.02B 106M 711M 277M 3.45B 276M 270M 11.95B |
| Net income | -127M -111M -102M -94.83M -180M -12.08B -183M -1.22B -476M -5.93B -476M -465M -20.56B | -164M -144M -133M -123M -234M -15.67B -237M -1.59B -617M -7.69B -617M -603M -26.67B |
| Net Debt | -203M -178M -164M -152M -289M -19.37B -293M -1.96B -763M -9.51B -763M -746M -32.97B | -16.01M -14.02M -12.91M -11.99M -22.76M -1.53B -23.07M -155M -60.15M -749M -60.11M -58.79M -2.6B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- KALV Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
